Search Results for keywords:"Schedule I controlled substance"

Found 2 results
Skip to main content

Search Results: keywords:"Schedule I controlled substance"

  • Type:Notice
    Citation:86 FR 9536
    Reading Time:about 2 minutes

    The Drug Enforcement Administration (DEA) has announced that North Star Holdings California, LLC, has applied to become a registered bulk manufacturer of marihuana, a Schedule I controlled substance. This application is part of a DEA program that regulates the cultivation of marihuana for scientific and medical research purposes. The DEA will review this and similar applications to ensure compliance with relevant laws and regulations, ensuring that adequate measures are in place to prevent illegal distribution. Interested parties may submit comments or objections to the DEA regarding this application before April 19, 2021.

    Simple Explanation

    The DEA is thinking about letting a company, North Star Holdings California, grow a special type of plant called marihuana for scientists and doctors to study. People can tell the DEA what they think about this idea until April 19, 2021.

  • Type:Notice
    Citation:90 FR 13884
    Reading Time:about 2 minutes

    The Drug Enforcement Administration (DEA) received an application from Baxter Research Lab to register as a bulk manufacturer of marihuana, a Schedule I controlled substance. This registration would allow Baxter to produce large quantities of active pharmaceutical ingredients (APIs) for research purposes. The DEA will review the application to ensure all legal and safety measures are in place to prevent misuse. Comments or objections regarding this application can be submitted electronically until May 27, 2025.

    Simple Explanation

    The DEA is thinking about letting a company called Baxter Research Lab make a lot of a special plant called marihuana for scientific experiments, but only if they follow all the rules to keep it safe and not let it get into the wrong hands.